info@seagull-health.com

SeagullHealth

语言:

Homepage

Drugs

Anagrelide(Xagrid)

Names

Agrylin,安归宁,阿那格雷

Indicatons

A platelet-reducing agent for treating thrombocythemia secondary to myeloproliferative neoplasms.

Price:

Manufacturer:

Shire

Dosage form:

CAPSULE

Validity period:

24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Xagrid(Anagrelide) Instructions:Uses,Dosage, Side Effects

AGRYLIN is indicated specifically for managing thrombocythemia (elevated platelet count) that is secondary to underlying myeloproliferative neoplasms. These conditions include Essential Thrombocythemia (ET), Polycythemia Vera (PV), and Chronic Myelogenous Leukemia (CML).

The treatment aims to reduce the high platelet count, thereby lowering the associated risk of thrombotic events and ameliorating related thrombo-hemorrhagic symptoms.

Generic name

Anagrelide(Xagrid)

English name

Anagrelide

Alternative Names

Agrylin,安归宁,阿那格雷

Drug prices

Indications

Treatment of thrombocythemia, secondary to myeloproliferative neoplasms (e.g., Essential Thrombocythemia, Polycythemia Vera), to reduce the elevated platelet count, the risk of thrombosis, and to ameliorate associated thrombo-hemorrhagic symptoms.

Therapeutic Target

The precise mechanism is not fully elucidated, but it suppresses megakaryocytopoiesis, reducing platelet production. It is also a phosphodiesterase 3 (PDE3) inhibitor.

Active Ingredients

Anagrelide

Dosage Form

CAPSULE

Specifications

0.5mg * 100 tablets/capsules

Dosage and Administration

Recommended starting dose is 0.5 mg four times daily or 1 mg twice daily.

Related Columns

Recommended articles

How Effective is Anagrelide (Agrylin) in Treatment?

Anagrelide (Agrylin) is a drug specifically used to treat thrombocythemia, and it is particularly suitable for secondary thrombocythemia associated with myeloproliferative neoplasms.How Effective is A...

What are the side effects of Anagrelide (Agrylin)?

Anagrelide (Agrylin) is a specific drug used to treat secondary thrombocythemia in myeloproliferative neoplasms. It reduces the risk of thrombosis by lowering platelet count. Its clinical use requires...

Indications for Anagrelide (Agrylin)

Anagrelide (Agrylin) is a thrombocytopenic agent primarily used to treat thrombocythemia caused by myeloproliferative neoplasms.Indications for Anagrelide (Agrylin)Reducing Elevated Platelet CountThis...

Precautions for Anagrelide (Agrylin) Administration

Anagrelide (Agrylin) is a thrombocytopenic agent primarily used to treat thrombocythemia secondary to myeloproliferative neoplasms. It reduces platelet counts, lowers the risk of thrombosis, and impro...

How to Use Anagrelide (Agrylin)

Anagrelide (Agrylin) is a selective thrombocytopenic agent primarily used to treat thrombocythemia secondary to myeloproliferative neoplasms. It reduces the risk of thrombosis and improves related sym...

Indications for Anagrelide (Agrylin)

Anagrelide (Agrylin) is a thrombocytopenic agent primarily indicated for the treatment of thrombocythemia caused by myeloproliferative neoplasms.Indications for Anagrelide (Agrylin)Reducing Elevated P...

Departments